Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CTSG | P08311 | 1/20 | 0.38 |
| ▸ | CMA1 | P23946 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.38 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5328428 | 0.77 | ALDH1A1 (0.36) | MEN1KMT2AFUCA1SIGMAR1CYP19A1 | |
| SCHEMBL5308283 | 0.74 | ALDH1A1 (0.37) | SIGMAR1ACHE | |
| SCHEMBL5286644 | 0.74 | ALDH1A1 (0.37) | KMT2ASIGMAR1ELANEGSK3AGSK3B | |
| SCHEMBL1078734 | 0.72 | ACHE (0.47) | MEN1KMT2AFUCA1SIGMAR1F2 | |
| SCHEMBL5293654 | 0.72 | ALDH1A1 (0.35) | MEN1KMT2A | |
| SCHEMBL7137668 | 0.71 | SIGMAR1 (0.41) | MEN1KMT2AFUCA1SIGMAR1F2 | |
| Hydrochloric Acid SCHEMBL18789343 | 0.71 | ACHE (0.46) | MEN1KMT2AFUCA1SIGMAR1KDM4E | |
| SCHEMBL5322094 | 0.71 | ACHE (0.42) | KMT2AFUCA1SIGMAR1ACHE | |
| SCHEMBL5300171 | 0.70 | ABL1 (0.38) | SIGMAR1 | |
| SCHEMBL5329132 | 0.68 | KMT2A (0.34) | MEN1KMT2AFUCA1CYP19A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9863048-B2 | Synthesis and use of biobased imidazolium carboxylates | Université de Bourgogne (FR) | 2018-01-09 | — | — | US | disclosed |
| US-20160002796-A1 | SYNTHESIS AND USE OF BIOBASED IMIDAZOLIUM CARBOXYLATES | Université de Bourgogne (FR) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002796-A1 | SYNTHESIS AND USE OF BIOBASED IMIDAZOLIUM CARBOXYLATES | IDH2, IDH1, HOGA1 | MEN1 2493/4885KMT2A 4032/4885FUCA1 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.